H1 2025 Financial Results
Access all the information about Grifols' H1 Financial Results.
Showing 238 search results
Grifols expands U.S. diagnostic manufacturing with a new facility in San Diego
Grifols’ Biotest launches Yimmugo® in the United States
Grifols creates the Board of Directors' Strategy Committee
Grifols invests more than €200 million in fighting Alzheimer's
Grifols Reports 7% Revenue Growth to EUR 3,677m and Net profit to EUR 177m in H1’25 while executes on its Value Creation Plan
Grifols will build new manufacturing site in Spain to double its plasma fractionation capacity in Europe
Publications
Links to our latest financial and sustainability reports and other recent publications.
Financial Report
Explore our last financial and earnings annual report.
Sustainability Report
Integrated and Sustainability Annual Report.
Position Paper
The differential value of plasma-derived medicinal products (PDMPs).
Press Kit
Explore our Press Kit to find key facts and figures on Grifols.
Media Contacts
If you're a journalist or media professional with a question, contact our media relations team.